SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-008327
Filing Date
2024-01-30
Accepted
2024-01-30 17:03:13
Documents
1
Period of Report
2024-01-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244587-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm244587-1_4seq1.xml 4 13864
  Complete submission text file 0001104659-24-008327.txt   15454
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Morabito Christopher (Reporting) CIK: 0001859284 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 24579051